Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11926499 | 0.93 | MEN1 (0.35) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21276277 | 0.93 | — | — | |
| SCHEMBL21276418 | 0.91 | MEN1 (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL10039111 | 0.91 | L3MBTL1 (0.34) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21531860 | 0.90 | MAPT (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21276441 | 0.90 | MAPT (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21276370 | 0.90 | MAPT (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21276417 | 0.90 | MAPT (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21276259 | 0.90 | MAPT (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A | |
| SCHEMBL21276437 | 0.90 | MAPT (0.33) | MEN1ALDH1A1MAPTHPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240032421-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | UDC IRELAND LIMITED (IE) | 2024-01-25 | — | — | US | disclosed |
| US-20240032421-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | UDC IRELAND LIMITED (IE) | 2024-01-25 | — | — | US | disclosed |
| US-11800798-B2 | Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device | UDC IRELAND LIMITED (IE) | 2023-10-24 | — | — | US | disclosed |
| US-11800798-B2 | Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device | UDC IRELAND LIMITED (IE) | 2023-10-24 | — | — | US | disclosed |
| US-20210249611-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | UDC IRELAND LTD (IE) | 2021-08-12 | — | — | US | disclosed |
| US-11038122-B2 | Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device | UDC IRELAND LIMITED (IE) | 2021-06-15 | — | — | US | disclosed |
| US-20190334098-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | UDC IRELAND LTD (IE) | 2019-10-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11038122-B2 | Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device | TMEM109, SLC39A11, SLC39A14 | MEN1 1647/4885ALDH1A1 981/4885MAPT 1229/4885 |
| US-20210249611-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | TMEM109, SLC39A11, SLC39A14 | MEN1 1647/4885ALDH1A1 981/4885MAPT 1229/4885 |
| US-11800798-B2 | Charge transporting material, organic electroluminescent element, light emitting device, display device and illumination device | TMEM109, SLC39A11, SLC39A14 | MEN1 1647/4885ALDH1A1 981/4885MAPT 1229/4885 |
| US-20240032421-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | TMEM109, SLC39A11, SLC39A14 | MEN1 1647/4885ALDH1A1 981/4885MAPT 1229/4885 |
| US-20190334098-A1 | Charge Transporting Material, Organic Electroluminescent Element, Light Emitting Device, Display Device And Illumination Device | NR2E3, OR51E2, GNA11 | MEN1 2635/4885ALDH1A1 1596/4885MAPT 2515/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.